Abstract: | The Chinese Neuromodulation Society experts were commissioned to written a consensus and treatment recommendation for the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until November 2017, regarding depression, pain, movement disorders, stroke, epilepsy, tinnitus, anxiety disorders, obsessive compulsive disorder, schizophrenia, craving/addiction and sleep disorder, each summary clinical recommendation is presented with the substantiating peer reviewed, published evidence supporting that recommendation. It summarizes current evidence for the safety and efficacy of the use of rTMS therapy, aims to determine how to optimize rTMS protocols and techniques to give them relevance in routine clinical practice. In addition, professionals carrying out rTMS protocols should undergo rigorous training to ensure the quality of the technical realization, guarantee the proper care of patients, and maximize the chances of success. |